基本信息
浏览量:51
职业迁徙
个人简介
Cancer drug development professional with comprehensive experience encompassing clinical research, translational medicine, and discovery research.
• Clinical R&D expertise comprises compound development strategy, clinical trial design, operational support and problem-solving of clinical trials, data analysis/interpretation and reporting.
• Discovery research and translational medicine skills cover drug target identification/validation; compound screening; selection and advancement of lead drug candidates; regulatory agency filing (IND/CTA) and early clinical development.
• Outstanding communication skills fostered through leadership of cross-functional, multidisciplinary teams; extensive publications in premier scientific journals; oral presentations at international scientific meetings and to corporate senior management; and authorship of clinical and regulatory documents.
• Clinical R&D expertise comprises compound development strategy, clinical trial design, operational support and problem-solving of clinical trials, data analysis/interpretation and reporting.
• Discovery research and translational medicine skills cover drug target identification/validation; compound screening; selection and advancement of lead drug candidates; regulatory agency filing (IND/CTA) and early clinical development.
• Outstanding communication skills fostered through leadership of cross-functional, multidisciplinary teams; extensive publications in premier scientific journals; oral presentations at international scientific meetings and to corporate senior management; and authorship of clinical and regulatory documents.
研究兴趣
论文共 54 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Jeffrey M. Axten,Jesus R. Medina, Arthur Shu, William H. Li,Yanhong Feng, M. Phillip Deyoung, Christine M. Gardiner, Antony R. Chadderton,Melissa Dumble,Qi Liu,Sridhar Rabindran
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn